JP2013535438A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535438A5 JP2013535438A5 JP2013519738A JP2013519738A JP2013535438A5 JP 2013535438 A5 JP2013535438 A5 JP 2013535438A5 JP 2013519738 A JP2013519738 A JP 2013519738A JP 2013519738 A JP2013519738 A JP 2013519738A JP 2013535438 A5 JP2013535438 A5 JP 2013535438A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- solvent
- formulation
- compound
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002193 Pain Diseases 0.000 claims 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 11
- 239000002904 solvent Substances 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 9
- 238000009472 formulation Methods 0.000 claims 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- 239000011877 solvent mixture Substances 0.000 claims 4
- 208000004550 Postoperative Pain Diseases 0.000 claims 3
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims 2
- 206010058019 Cancer Pain Diseases 0.000 claims 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 2
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000001704 evaporation Methods 0.000 claims 2
- 230000008020 evaporation Effects 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 229960004380 tramadol Drugs 0.000 claims 2
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims 2
- 238000002441 X-ray diffraction Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000002269 spontaneous effect Effects 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36334410P | 2010-07-12 | 2010-07-12 | |
| US61/363,344 | 2010-07-12 | ||
| PCT/US2011/043528 WO2012009262A2 (en) | 2010-07-12 | 2011-07-11 | Diclofenac salt of tramadol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535438A JP2013535438A (ja) | 2013-09-12 |
| JP2013535438A5 true JP2013535438A5 (https=) | 2014-08-28 |
Family
ID=45470017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013519738A Pending JP2013535438A (ja) | 2010-07-12 | 2011-07-11 | トラマドールのジクロフェナク塩 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130065957A1 (https=) |
| EP (1) | EP2593096A4 (https=) |
| JP (1) | JP2013535438A (https=) |
| KR (1) | KR20130129070A (https=) |
| CN (1) | CN102970989A (https=) |
| PH (1) | PH12012502484A1 (https=) |
| SG (1) | SG185642A1 (https=) |
| TW (1) | TW201206421A (https=) |
| WO (1) | WO2012009262A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102358377B1 (ko) | 2016-12-28 | 2022-02-03 | 히사미쓰 세이야꾸 가부시키가이샤 | 첩부제 |
| JP6761553B1 (ja) * | 2020-02-12 | 2020-09-23 | 久光製薬株式会社 | ジクロフェナクナトリウム含有貼付剤 |
| JP6744512B1 (ja) * | 2020-02-12 | 2020-08-19 | 久光製薬株式会社 | ジクロフェナクナトリウム含有貼付剤 |
| EP4180105A4 (en) * | 2020-07-13 | 2024-08-28 | NGK Insulators, Ltd. | REFINING PROCESS |
| US11872320B2 (en) | 2021-02-25 | 2024-01-16 | Hisamitsu Pharmaceutical Co., Inc. | Method for treating osteoarthritis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19927689A1 (de) * | 1999-06-17 | 2000-12-21 | Gruenenthal Gmbh | Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
| DE19927688A1 (de) * | 1999-06-17 | 2000-12-21 | Gruenenthal Gmbh | Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
| DE19940944B4 (de) * | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
| DE10059020A1 (de) * | 2000-11-28 | 2002-05-29 | Gruenenthal Gmbh | Parenteral applizierbare Darreichungsformen |
| US20100029704A1 (en) * | 2007-01-29 | 2010-02-04 | Medrx Co., Ltd. | Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof |
| EP2177215A1 (en) * | 2008-10-17 | 2010-04-21 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of tramadol and NSAIDs |
-
2011
- 2011-07-11 EP EP11807342.8A patent/EP2593096A4/en not_active Withdrawn
- 2011-07-11 JP JP2013519738A patent/JP2013535438A/ja active Pending
- 2011-07-11 PH PH1/2012/502484A patent/PH12012502484A1/en unknown
- 2011-07-11 CN CN2011800318362A patent/CN102970989A/zh active Pending
- 2011-07-11 KR KR1020127032253A patent/KR20130129070A/ko not_active Withdrawn
- 2011-07-11 SG SG2012084810A patent/SG185642A1/en unknown
- 2011-07-11 WO PCT/US2011/043528 patent/WO2012009262A2/en not_active Ceased
- 2011-07-12 TW TW100124569A patent/TW201206421A/zh unknown
-
2012
- 2012-11-01 US US13/666,786 patent/US20130065957A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3035088T3 (en) | Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol | |
| JP2022140637A (ja) | 結晶性（８Ｓ，９Ｒ）－５－フルオロ－８－（４－フルオロフェニル）－９－（１－メチル－１Ｈ－１，２，４－トリアゾール－５－イル）－８，９－ジヒドロ－２Ｈ－ピリド［４，３，２－ｄｅ］フタラジン－３（７Ｈ）－オントシレート塩 | |
| JP6669932B2 (ja) | ボルチオキセチンのパモ酸塩及びその結晶形 | |
| JP2013535438A5 (https=) | ||
| BRPI1011015B1 (pt) | método para sintetizar pirfenidona | |
| WO2013029431A1 (zh) | 苯并二氮杂卓衍生物的托西酸盐及其多晶型、它们的制备方法和用途 | |
| WO2016038532A1 (en) | Amorphous treprostinil diethanolamine | |
| HRP20171511T1 (hr) | Ivabradin-hidroklorid, oblik iv | |
| CN102827153A (zh) | 阿齐沙坦的晶型及其制备方法 | |
| JP2015134774A (ja) | 医薬化合物の結晶化 | |
| US11242340B2 (en) | Crystal forms of demethyleneberberine hydrochloride and preparation method therefor | |
| US20210171536A1 (en) | Compound of eoc315 mod.i crystal form and preparation method thereof | |
| CN109010348B (zh) | 一种拉西地平-螺内酯共无定形固体分散体及其制备 | |
| WO2021143898A1 (zh) | Arb代谢产物与nep抑制剂的复合物新晶型及其制备方法 | |
| JP6522094B2 (ja) | ４−［２−ジメチルアミノ−１−（１−ヒドロキシシクロヘキシル）エチル］フェニル４−メチルベンゾエートヒドロクロリドの多形体、それらを作製する方法及びそれらの使用 | |
| CN105237611B (zh) | 积雪草酸氨丁三醇盐晶型及其制备方法 | |
| ES2303768B1 (es) | Nueva forma cristalina de moxifloxacino clorhidrato. | |
| WO2018078383A1 (en) | Pharmaceutical composition comprising amorphous selexipag | |
| CA2835232C (en) | A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof | |
| Zhou et al. | Co-amorphous system of icaritin–sodium taurodeoxycholate with improved solubility, antitumor efficacy and oral bioavailability | |
| US20240307427A1 (en) | Remdesivir cocrystal, compositions and methods thereof | |
| RU2018129465A (ru) | Винорелбина монотартрат и его фармацевтическое применение | |
| JP2008531516A (ja) | レルカニジピン遊離塩基 | |
| AU2016212555A1 (en) | Sunitinib prodrug and pharmaceutical composition | |
| CN112552308B (zh) | 一种5-溴代双去甲基汉防己甲素双甲酸乙酯晶型及其制备方法 |